Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A (F13A1): Decreased Platelet-Megakaryocyte F13A1 Expression and Clot Contraction in RUNX1 Haplodeficiency
Del Carpio-Cano, F.; Songdej, N.; Guan, L.; Mao, G.; Goldfinger, L. E.; Wurtzel, J. G. T.; Lee, K.; Lambert, M. P.; Poncz, M.; Rao, A. K.
Show abstract
BackgroundGermline RUNX1 haplodeficiency (RHD) is associated with thrombocytopenia, platelet dysfunction and predisposition to myeloid malignancies. Platelet expression profiling of a RHD patient showed decreased F13A1, encoding for the A subunit of factor XIII, a transglutaminase that cross-links fibrin and induces clot stabilization. FXIII-A is synthesized by hematopoietic cells, megakaryocytes and monocytes. AimsTo understand RUNX1 regulation of F13A1 expression in platelet/megakaryocyte and the mechanisms and consequences of decreased F13A1 in RHD. MethodsWe performed studies in platelets, HEL cells and human CD34+ cell-derived megakaryocytes including on clot contraction in cells following small inhibitor (si)RNA knockdown (KD) of RUNX1 or F13A1. ResultsPlatelet F13A1 mRNA and protein were decreased in our index patient and in two siblings from an unrelated family with RHD. Platelet-driven clot contraction was decreased in the patient and affected daughter. Promoter studies in HEL cells showed that RUNX1 regulates F13A1 transcription; RUNX1 overexpression increased and (si)RNA RUNX1 KD reduced F13A1 promoter activity and protein. Following RUNX1 or F13A1 KD clot contraction by HEL cells was decreased as were FXIII-A surface expression, myosin light chain phosphorylation and PAC1 binding upon activation. F13A1 expression and clot contraction were impaired on RUNX1 downregulation in human megakaryocytes. ConclusionsRUNX1 regulates platelet-megakaryocyte F13A1 expression, which is decreased in RHD, reflecting regulation of a coagulation protein by a hematopoietic transcription factor. Platelet and megakaryocyte clot contraction is decreased in RHD, related to multiple impaired mechanisms including F13A1 expression, myosin phosphorylation and IIb{beta}3 activation. Scientific category - Platelets and thrombopoiesis EssentialsO_LIRUNX1 regulates expression of FXIII-A chain (F13A1) in megakaryocytes (MK) and platelets. C_LIO_LIPlatelet and MK F13A1 expression and clot contraction are decreased in RUNX1 deficiency. C_LIO_LIMK clot contraction, myosin phosphorylation and PAC1-binding are impaired in F13A1 deficiency. C_LIO_LIDefective clot contraction in RHD arises from defects in multiple platelet-MK mechanisms. C_LI
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Utility of thromboelastography with platelet mapping (TEG-PM) for monitoring platelet transfusion in qualitative platelet disorders 97%
- Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity 96%
- Quantitative super-resolution imaging of platelet degranulation reveals differential release of VWF and VWF propeptide from alpha-granules 95%
Similar papers in this journal
- cAMP prevents antibody-mediated thrombus formation in COVID-19 94%
- Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments 93%
- Temporal in vivo platelet labelling in mice reveals age-dependent receptor expression and conservation of specific mRNAs 92%
Similar papers in this journal
- HAND1 knockdown disrupts trophoblast global gene expression 91%
- Nephrotic Syndrome-Associated Hypercoagulopathy is Alleviated by Nuclear Receptor Agonist Therapy with both Pioglitazone and Glucocorticoids 89%
- Erythropoietin production?by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation 89%
Similar papers in this journal
- Sickle red blood cell derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor 95%
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 93%
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 89%
Similar papers in this journal
- Protection of β2GPI Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet Activation 93%
- Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 92%
- Platelet dysfunction reversal with cold-stored vs. room temperature-stored platelet transfusions 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.